Luis López-Cortés

9PUBLICATIONS
45CO-AUTHORS
Innate immunityRespiratory diseasesGene and molecular therapyBehavioural epidemiologyGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 05, 2026
Elevated Plasma GDF-15 Levels are Associated with the Immune Non-Responder Phenotype in People with HIV.

|Feb 20, 2026
Circulating miRNA Signatures Associated with Atherosclerosis and Cardiometabolic Comorbidities in People with HIV.

Marina Martinez-Velasco, José Francisco Sánchez-Herrero, Laura Ibañez

|Oct 10, 2025
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study).

Sergio Serrano-Villar, Laura Martín-Pedraza, Juan Tiraboschi

|Apr 01, 2025
Mitochondrial Disorders After 12 Months of Human Immunodeficiency Virus Type 1 Preexposure Prophylaxis Based on Tenofovir Disoproxil Fumarate Plus Emtricitabine in Healthy Adults.

Esperanza Muñoz-Muela, Marta Mejías-Trueba, Ana Serna-Gallego

|Jun 25, 2024
Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life.

Marta Mejías-Trueba, Alicia Gutierrez-Valencia, Silvia Llaves-Flores

|Feb 24, 2024
DOLAMA 200: Effectiveness and Safety of a Dual Therapy with Dolutegravir Plus Lamivudine in Treatment-Experienced HIV-1 Infected Real World Participants in Spain.

Sergio Sequera-Arquelladas, Carmen Hidalgo-Tenorio, Luis López-Cortés

Pageof 2

Frequent Collaborators

2 joint publications

Luis Eduardo López-Cortés

2 joint publications

Alicia Gutierrez-Valencia

2 joint publications

Carmen Hidalgo-Tenorio

1 joint publications

Marta Mejías-Trueba